K-554 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,971 results for “K-554”

Trials

View all 1134 →

A Randomized Controlled Test of the Effects of CHI-554 on Fear.

84 participants · First posted Oct 8, 2020

Safety of Co-Administered CHI-554 and Alcohol

29 participants · First posted Apr 7, 2022

Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours

41 participants · First posted Apr 19, 2012

Drugs

View all 752 →

SPD-554

R-554

BP-554

Organizations

View all 75 →

KIM IVANA K

United States

K-Group Beta, Inc.

United States

K-PAX Pharmaceuticals, Inc.

United States

News

View all 1010 →

Novo Nordisk Acquires Three Early-Stage Obesity Programs From Kallyope, Led by Weekly Peptide K-554

BriaCell's Bria-IMT™ Shows Promise in Metastatic Breast Cancer Phase 2 Trial

Acuitive Technologies' CITREPORE Receives FDA Clearance as Novel Bone Void Filler

Page 1 of 298